News

Allurion Unveils Groundbreaking Real-World Weight Loss Data

Allurion Unveils Groundbreaking Real-World Weight Loss Data

Allurion Presents Promising Results from Large-Scale Study

Allurion Technologies, Inc. (NYSE: ALUR), a company passionate about addressing obesity, has recently disclosed impressive outcomes during the Obesity Society’s Annual Conference. During this event, they presented two significant abstracts that shed light on the effectiveness of the Allurion Program.

Insights from the Largest Real-World Cohort

The first presentation outlines pivotal data collected from Allurion’s extensive real-world study, which stands as the largest of its kind. This research compiles results from 19,428 patients across 72 countries who participated in the Allurion Program from 2018 to 2023. Utilizing the Allurion Virtual Care Suite, the program provided digital tracking of participants’ results, showcasing an impressive average weight loss of 12.2% within just four months.

Significance of Real-World Data

Dr. Shantanu Gaur, Allurion's Founder and CEO, emphasized the importance of this data. He stated that while various clinical trials have explored intragastric balloons, substantial real-world data has been sparse. The findings from this cohort establish that the Allurion Program consistently enables clinically meaningful weight loss across a diverse range of patients, many of whom have previously struggled with traditional weight management methods.

Revolutionizing Outcomes for GLP-1 Non-Responders

In their second abstract, Allurion examined outcomes from 27 patients who had previously undergone treatment with liraglutide but saw minimal success. Alarmingly, the study showed that 55% of these individuals experienced no weight loss, and 45% achieved less than 5% weight reduction while on GLP-1 therapies. In stark contrast, those who transitioned to the Allurion Program experienced an astonishing average weight loss of 17.6% after just four months.

Implication for Obesity Treatments

Dr. Ram Chuttani, Chief Medical Officer of Allurion, pointed out the alarming trend noted in numerous clinical studies: more than a third of patients typically do not reach a weight loss of over 10% after a year on GLP-1 medications. With the traditionally lengthy timeline needed to assess the effectiveness of these treatments, the immediate and encouraging results observed with the Allurion Program may provide hope for those who haven't experienced success with other methodologies.

About Allurion Technologies

Allurion is dedicated to transforming the landscape of obesity treatment. Their flagship innovation, the Allurion Program, comprises the revolutionary Allurion Gastric Balloon—global first in swallowable, procedure-less intragastric balloons for weight loss. Complementing this is the Allurion Virtual Care Suite, a comprehensive digital platform that integrates essential features such as the Allurion Mobile App for patients, insightful data for healthcare providers, and advanced tools like Coach Iris AI, enhancing patient monitoring and treatment.

Beyond the Allurion Program, the Virtual Care Suite makes these tools accessible to healthcare providers with an aim to customize and manage weight-loss therapies, regardless of the method used. Notably, the Allurion Gastric Balloon is still an investigational device in the United States, signifying innovation in the field of weight management.

Frequently Asked Questions

What is the Allurion Program?

The Allurion Program is an innovative weight loss system that includes the Allurion Gastric Balloon and the Allurion Virtual Care Suite, which provides personalized monitoring and support.

How effective is the Allurion Program?

Recent studies show that patients participating in the Allurion Program experienced an average weight loss of 12.2% over four months, with some achieving as much as 17.6% weight reduction.

Who can benefit from the Allurion Program?

The program is suitable for individuals struggling with weight management, including those who have not achieved desired results using other obesity treatments such as GLP-1 medications.

Are the devices used in the program FDA approved?

The Allurion Gastric Balloon is currently investigational in the United States; however, the program has been positively received in other countries.

What kind of support does the Allurion Virtual Care Suite offer?

The Allurion Virtual Care Suite features a mobile app for patients, data and insights for healthcare providers, and tools for remote monitoring to enhance patient success in weight management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Rokt's 164% Growth Shows Checkout Ads Have Real Muscle

Updated Category News Views 116

Checkout screens have become valuable real estate, and Rokt is planting a flag right in the middle of them. The New York ecommerce technology company landed on Deloitte's 2026 Technology Fast 500 after posting 164% revenue growth from 2022 through 2025. That is a meaningful number, not decorative corporate confetti, especially in a digital-ad market where plenty of...

Continue Reading
Trucking Hub Bets on Faster MVR Checks Nationwide Today

Updated Category News Views 98

Driver paperwork is where plenty of supposedly modern fleet systems still go to die. Trucking Hub’s Nov. 18 launch of GetMVR.com takes a clean swing at that mess: an online platform for ordering Motor Vehicle Records in all 50 states, with instant reports available in 48. It is not glamorous software, and frankly that is why it may matter. Fleets do not lose sleep over...

Continue Reading
Marina del Rey's Travel Award Brings Fresh Attention

Updated Category News Views 56

A harbor town just got handed a useful little megaphone. On November 18, 2026, the Marina del Rey Tourism Board said Marina del Rey had been selected as a winner in Good Housekeeping's 2027 Travel Awards. That is not a quarterly earnings event, and nobody ought to dress it up as one. Still, in the visitor economy, recognition from a broad consumer publication can matter...

Continue Reading
WYBOT's New Robots Push Hands-Free Pool Care in Lyon

Updated Category News Views 64

A pool robot climbing out of the water to dock itself is the sort of demo that makes people stop mid-aisle at a trade show. WYBOT brought precisely that kind of attention-grabber to Piscine Global Lyon 2026, running November 17–20 at Eurexpo Lyon. The company is showing a broader lineup, but the M3 Pro is plainly the headline act: WYBOT calls it the world's first...

Continue Reading
Whole-House Remodels Need a Plan Before Any Finishes

Updated Category News Views 14

A remodel gets expensive the minute somebody falls in love with tile before checking what sits behind the wall. Adam Sherman’s central point in the HelloNation article is refreshingly unglamorous: treat the house as one working system before treating it as a collection of rooms crying out for cosmetic rescue. That sounds obvious until you see how often a kitchen...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 74

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 160

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
Kids First Data Sharing Raises Pediatric Research Bar

Updated Category News Views 98

Thirty-eight thousand children’s records are not a headline gimmick; they are a serious argument for treating research data as an asset that must keep working after the first study ends. The Gabriella Miller Kids First Data Resource Center’s ten-year review, published in the September 2026 issue of The American Journal of Human Genetics, makes that argument with...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 62

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Specialty Chemicals Need Demand Before Capacity Bets

Updated Category News Views 83

Empty reactor space does not get filled because everybody suddenly loves reshoring. SOCMA's 2027 Contract Manufacturing Outlook makes that stubborn fact hard to dodge: nearly 70% of surveyed respondents expect North American manufacturing activity to rise over the next three years, yet 79.5% say stronger, more predictable customer demand is critical before future...

Continue Reading

Top 5 Most Recently Viewed Articles

CREFC's 1Q Sentiment Index Reflects Industry Concerns

Updated Category News Views 225

Understanding the Decline in CREFC's Sentiment Index The CRE Finance Council (CREFC), representing the vast $6.2 trillion commercial and multifamily real estate finance sector, recently unveiled its latest survey results. The 1Q 2025 Sentiment Index, which is an essential barometer for industry sentiment, has experienced a steep dive, marking a significant shift in...

Continue Reading
Rubicon Organics Inc. Posts Impressive Growth in 2024 Results

Updated Category News Views 26025

Financial Highlights of 2024 Rubicon Organics Inc. has announced outstanding financial results for the year ended December 31, 2024. The Company, a prominent player in the organic cannabis sector, reported a record high net revenue of $48.7 million, which is a prestigious 21% increase from the previous year. In the fourth quarter alone, Rubicon Organics realized a net...

Continue Reading
Amazon Web Services Boosts Cloud Capacity with $5 Billion Venture

Updated Category News Views 134

Amazon Web Services Expands Reach in Asia Pacific Amazon.com, Inc. (NASDAQ: AMZN), through its cloud computing branch, Amazon Web Services (AWS), has recently announced the establishment of the AWS Asia Pacific (Thailand) Region. This expansion comes with an impressive planned investment exceeding $5 billion. Investment Insights and Customer Benefits This significant...

Continue Reading
Cellectar Biosciences Secures $5.8 Million Through Warrant Exercise

Updated Category News Views 200

Significant Fundraising by Cellectar Biosciences In an exciting development for the biotechnology sector, Cellectar Biosciences, Inc. (NASDAQ: CLRB), a leading company focused on advancing cancer treatments, has successfully raised approximately $5.8 million through a strategic agreement with multiple institutional investors. This figure represents the gross proceeds from...

Continue Reading
Waldorf Astoria Hosts Dazzling Tennis Event in Ballroom

Updated Category News Views 43

Tennis in the Heart of Luxury Well, here’s a twist that even Arthur Ashe couldn’t have envisioned—the famed Waldorf Astoria in New York is rolling out the green carpet right there in their iconic ballroom. On August 27, they're busting out the tennis rackets where chandeliers usually watch ballroom dancing. You know, once in a while, even us grizzled investors have...

Continue Reading